tiprankstipranks
Trending News
More News >
Park Ha Biological Technology Co., Ltd. (PHH)
:PHH
US Market

Park Ha Biological Technology Co., Ltd. (PHH) Ratios

Compare
70 Followers

Park Ha Biological Technology Co., Ltd. Ratios

PHH's free cash flow for Q2 2018 was $―. For the 2018 fiscal year, PHH's free cash flow was decreased by $ and operating cash flow was $―. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.87 1.75 0.96 0.41-
Quick Ratio
1.82 1.67 0.92 0.14-
Cash Ratio
0.36 0.83 0.24 0.06-
Solvency Ratio
0.32 0.70 0.09 -0.38-
Operating Cash Flow Ratio
0.63 0.10 0.61 -0.43-
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00-
Net Current Asset Value
$ 1.27M$ 923.75K$ -103.81K$ -698.81K-
Leverage Ratios
Debt-to-Assets Ratio
0.02 0.01 0.01 0.06-
Debt-to-Equity Ratio
0.05 0.03 0.17 -0.06-
Debt-to-Capital Ratio
0.04 0.03 0.15 -0.06-
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00-
Financial Leverage Ratio
2.05 2.24 16.76 -1.03-
Debt Service Coverage Ratio
0.00 0.00 1.14K -372.49-
Interest Coverage Ratio
0.00 0.00 1.02K -419.58-
Debt to Market Cap
0.00 0.00 0.00 0.00-
Interest Debt Per Share
<0.01 <0.01 <0.01 <0.01-
Net Debt to EBITDA
-0.58 -0.83 -2.49 0.08-
Profitability Margins
Gross Profit Margin
91.81%87.35%73.47%66.58%-
EBIT Margin
33.32%48.05%9.91%-51.96%-
EBITDA Margin
34.27%48.82%11.50%-47.77%-
Operating Profit Margin
33.32%48.01%10.26%-53.81%-
Pretax Profit Margin
33.31%48.05%9.90%-52.09%-
Net Profit Margin
20.09%34.65%9.97%-52.09%-
Continuous Operations Profit Margin
20.09%34.65%9.97%-52.09%-
Net Income Per EBT
60.32%72.11%100.68%100.00%-
EBT Per EBIT
99.96%100.09%96.44%96.80%-
Return on Assets (ROA)
15.52%37.62%7.60%-81.61%-
Return on Equity (ROE)
38.00%84.15%127.30%83.88%-
Return on Capital Employed (ROCE)
50.92%115.52%131.11%89.09%-
Return on Invested Capital (ROIC)
30.37%81.55%112.40%92.26%-
Return on Tangible Assets
15.56%37.76%7.62%-81.61%-
Earnings Yield
3.80%325206.87%73014.50%-0.17%-
Efficiency Ratios
Receivables Turnover
2.15 3.46 1.26 11.68-
Payables Turnover
8.12 1.58 3.92 3.48-
Inventory Turnover
2.73 3.24 5.41 0.98-
Fixed Asset Turnover
13.63 34.91 30.55 8.72-
Asset Turnover
0.77 1.09 0.76 1.57-
Working Capital Turnover Ratio
2.11 5.93 -4.88 0.00-
Cash Conversion Cycle
258.64 -13.38 264.64 297.72-
Days of Sales Outstanding
170.04 105.50 290.13 31.25-
Days of Inventory Outstanding
133.58 112.52 67.51 371.28-
Days of Payables Outstanding
44.97 231.40 92.99 104.80-
Operating Cycle
303.61 218.02 357.63 402.52-
Cash Flow Ratios
Operating Cash Flow Per Share
0.04 <0.01 0.06 -0.02-
Free Cash Flow Per Share
0.03 <0.01 0.05 -0.02-
CapEx Per Share
<0.01 <0.01 <0.01 <0.01-
Free Cash Flow to Operating Cash Flow
0.91 0.82 0.99 1.03-
Dividend Paid and CapEx Coverage Ratio
11.22 5.58 121.30 -38.57-
Capital Expenditure Coverage Ratio
11.22 5.58 121.30 -38.57-
Operating Cash Flow Coverage Ratio
13.66 4.02 55.06 -14.14-
Operating Cash Flow to Sales Ratio
0.40 0.05 0.75 -0.53-
Free Cash Flow Yield
7.04%39641.60%545960.31%-0.18%-
Valuation Ratios
Price-to-Earnings (P/E) Ratio
26.30 <0.01 <0.01 -594.28-
Price-to-Sales (P/S) Ratio
5.22 <0.01 <0.01 309.55-
Price-to-Book (P/B) Ratio
8.36 <0.01 <0.01 -498.46-
Price-to-Free Cash Flow (P/FCF) Ratio
14.20 <0.01 <0.01 -564.25-
Price-to-Operating Cash Flow Ratio
13.10 <0.01 <0.01 -578.88-
Price-to-Earnings Growth (PEG) Ratio
0.26 <0.01 >-0.01 0.00-
Price-to-Fair Value
8.36 <0.01 <0.01 -498.46-
Enterprise Value Multiple
14.64 -0.83 -2.48 -647.91-
Enterprise Value
11.95M -1.00M -548.25K 288.16M-
EV to EBITDA
14.64 -0.83 -2.48 -647.91-
EV to Sales
5.02 -0.41 -0.29 309.51-
EV to Free Cash Flow
13.66 -9.65 -0.38 -564.18-
EV to Operating Cash Flow
12.44 -7.92 -0.38 -578.80-
Tangible Book Value Per Share
0.06 0.04 <0.01 -0.02-
Shareholders’ Equity Per Share
0.06 0.04 <0.01 -0.02-
Tax and Other Ratios
Effective Tax Rate
0.40 0.28 >-0.01 0.00-
Revenue Per Share
0.09 0.09 0.07 0.04-
Net Income Per Share
0.02 0.03 <0.01 -0.02-
Tax Burden
0.60 0.72 1.01 1.00-
Interest Burden
1.00 1.00 1.00 1.00-
Research & Development to Revenue
0.02 0.01 0.03 0.00-
SG&A to Revenue
0.34 0.20 0.37 0.81-
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00-
Income Quality
2.01 0.15 7.54 1.03-
Currency in USD